Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Journal of Clinical Pharmacology|December 16, 2022
Prevalence of Baseline Cardiac Arrhythmias in Participants with Overweight or Obesity in Phase 1 Clinical Trials: Analysis of 24-Hour Holter Electrocardiogram RecordingsDorthe Skovgaard, Poul-Martin Haahr, Robert Lester, et al.Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 16, 2007
Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical responseJohan Svensson, Nick Finer, Pierre Bouloux, et al.European Heart Journal|June 28, 2007
Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trialChristian Torp-Pedersen, Ian Caterson, Walmir Coutinho, et al.Obesity (Silver Spring, Md.)|October 10, 2009
Early response to sibutramine in patients not meeting current label criteria: preliminary analysis of SCOUT lead-in periodIan Caterson, Walmir Coutinho, Nick Finer, et al.Obesity (Silver Spring, Md.)|January 29, 2008
Validation of a quantitative magnetic resonance method for measuring human body compositionAntonella Napolitano, Sam R Miller, Peter R Murgatroyd, et al.Journal of Hypertension|January 29, 2015
Joint scientific statement of the European Association for the Study of Obesity and the European Society of Hypertension: Obesity and early vascular ageingJens Jordan, Peter M Nilsson, Vasilios Kotsis, et al.Obesity (Silver Spring, Md.)|February 5, 2011
Efficacy and safety of CP-945,598, a selective cannabinoid CB1 receptor antagonist, on weight loss and maintenanceLouis J Aronne, Nick Finer, Priscilla A Hollander, et al.Obesity Facts|January 8, 2010
Management of obesity in adults: European clinical practice guidelinesConstantine Tsigos, Vojtech Hainer, Arnaud Basdevant, et al.Obesity Facts|September 17, 2011
Criteria for EASO-collaborating centres for obesity managementConstantine Tsigos, Vojtech Hainer, Arnaud Basdevant, et al.Journal of Cardiovascular Pharmacology|November 27, 2008
Tolerability of sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes: a preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) TrialAldo P Maggioni, Ian Caterson, Walmir Coutinho, et al.Pageof 5